首页 | 本学科首页   官方微博 | 高级检索  
检索        

CT guided 125iodine seed implantation for portal vein tumor thrombus in primary hepatocellular carcinoma
作者单位:ZHANG Fu-jun,LI Chuan-xing,JIAO De-chao,WU Pei-hong,DUAN Guang-feng,WU Yue-xia(State Key Laboratory of Oncology in South China,Department of Imaging and Interventional Radiology,Cancer Centre,Sun Yat-sen University,Guangzhou,Guangdong 510060,China);ZHANG Nian-hua(Department of Oncology, Guangdong Second Provincial Traditional Chinese Medicine Hospital,Guangzhou,Guangdong 510095,China) 
基金项目:Guangdong Science Committee,No. 2006B35802009;Department of Technology and Science of Guangzhou,No. 2007Z3-E0251;
摘    要:Background This study evaluated the clinical application of CT guided ^125iodine implantation in patients with portal vein tumor thrombus in primary hepatocellular carcinoma.
Methods The ten patients (9 males and 1 female, aged from 36 to 72 years) with portal vein tumor thrombus accompanying hepatocellular carcinoma had been treated with comprehensive therapy including surgery, transcatheter arterial chemoembolization, radiotherapy ablation, microwave ablation or percutaneous ethanol injection. The average diameter of each tumor thrombus was 21.5 mm × 30.5 mm. Seeds of 30 MBq ^125I were implanted 5 mm apart within the portal vein tumor thrombus. The follow-up after 4 months included enhanced spiral CT.
Results CT screening of the tumours indicated that 4 out of 10 patients showed complete response to the therapy, 5 partial response and 1 stable disease. Adverse effects included aggravated abdominal dropsy and temporarily increased transaminase, which were controlled by medical management. Severe complications such as haemorrhage, biliary fistula hepatic abscess, pancreatic fistula and hepatic function failure were not observed. Implanted seeds migrated to lung and left hepatic lobe in 1 case.
Conclusion CT guided implantation of ^125iodine seeds, can effectively treat portal vein tumor thrombus accompanying hepatocellular carcinoma with minimal damage and few complications.

关 键 词:^125I  碘酒  经脉肿瘤血栓  短程治疗  早期肝细胞癌

CT guided 125iodine seed implantation for portal vein tumor thrombus in primary hepatocellular carcinoma
Authors:ZHANG Fu-jun  LI Chuan-xing  JIAO De-chao  ZHANG Nian-hua  WU Pei-hong  DUAN Guang-feng  WU Yue-xia
Institution:ZHANG Fu-jun;LI Chuan-xing;JIAO De-chao;ZHANG Nian-hua;WU Pei-hong;DUAN Guang-feng;WU Yue-xia
Abstract:Background This study evaluated the clinical application of CT guided 125iodine implantation in patients with portal vein tumor thrombus in primary hepatocellular carcinoma.Methods The ten patients (9 males and 1 female,aged from 36 to 72 years) with portal vein tumor thrombus accompanying hepatocellular carcinoma had been treated with comprehensive therapy including surgery,transcatheter arterial chemoembolization,radiotherapy ablation,microwave ablation or percutaneous ethanol injection.The average diameter of each tumor thrombus was 21.5 mm×30.5 mm.Seeds of 30 MBq 125I were implanted 5 mm apart within the portal vein tumor thrombus.The follow-up after 4 months included enhanced spiral CT.Results CT screening of the tumours indicated that 4 out of 10 patients showed complete response to the therapy,5 partial response and 1 stable disease.Adverse effects included aggravated abdominal dropsy and temporarily increased transaminase,which were controlled by medical management.Severe complications such as haemorrhage,biliary fistula,hepatic abscess,pancreatic fistula and hepatic function failure were not observed.Implanted seeds migrated to lung and left hepatic lobe in 1 case.Conclusion CT guided implantation of 125iodine seeds,can effectively treat portal vein tumor thrombus accompanying hepatocellular carcinoma with minimal damage and few complications.
Keywords:125I  iodine seed implantation  portal vein tumor thrombus  brachytherapy  primary hepatocellular carcinoma
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中华医学杂志(英文版)》浏览原始摘要信息
点击此处可从《中华医学杂志(英文版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号